{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:53:51Z","timestamp":1648990431223},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1007\/bf00052508","type":"journal-article","created":{"date-parts":[[2004,10,31]],"date-time":"2004-10-31T06:01:29Z","timestamp":1099202489000},"page":"617-622","source":"Crossref","is-referenced-by-count":2,"title":["Medical treatment of eng-stage heart failure"],"prefix":"10.1007","volume":"10","author":[{"given":"Giorgio","family":"Binetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordano","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Mamprin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caporale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ferrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amando","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Glauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Troise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Fiocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/1071-9164(95)90010-1","volume":"1","author":"JN Cohn","year":"1995","unstructured":"Cohn, JN. Who should treat cardiac failure? J Cardiac Failure 1995;1:97.","journal-title":"J Cardiac Failure"},{"key":"CR2","first-page":"541","volume":"12","author":"MP Kaye","year":"1993","unstructured":"Kaye, MP. The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report-1993. J Heart Lung Transplant 1993;12:541?548.","journal-title":"J Heart Lung Transplant"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.CIR.89.1.450","volume":"89","author":"LW Stevenson","year":"1993","unstructured":"Stevenson, LW, Warner, SL, Steimle, AE, et al. The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection. Circulation 1993;89:450?457.","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"DH Ellison","year":"1991","unstructured":"Ellison, DH. The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann Intern Med 1991;114:97?105.","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"172A","DOI":"10.1016\/0735-1097(93)90485-J","volume":"22","author":"AJS Coats","year":"1993","unstructured":"Coats, AJS. Exercise rehabilitation in chronic heart failure. J Am Coll Cardiol 1993;22:172A-177A.","journal-title":"J Am Coll Cardiol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"107A","DOI":"10.1016\/0735-1097(93)90472-D","volume":"22","author":"RA Kelly","year":"1993","unstructured":"Kelly, RA, Smith, TW. Digoxin in heart failure: Implications of recent trials. J Am Coll Cardiol 1993;22:107A-112A.","journal-title":"J Am Coll Cardiol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.80.1.65","volume":"80","author":"DW Ferguson","year":"1989","unstructured":"Ferguson, DW, Berg, W, Sanders, JS, Roach, PJ, Kempf, JS, Kiezle, MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 1989;80:65?77.","journal-title":"Circulation"},{"key":"CR8","first-page":"479","volume":"14","author":"C Brater","year":"1994","unstructured":"Brater, C. The use of diuretics in congestive heart failure. Semin Nephrol 1994;14:479?484.","journal-title":"Semin Nephrol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0735-1097(84)80364-2","volume":"3","author":"M Packer","year":"1984","unstructured":"Packer, M, Medina, N, Yushak, M. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol 1984;3:1035?1043.","journal-title":"J Am Coll Cardiol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","volume":"71","author":"KT Weber","year":"1993","unstructured":"Weber, KT, Villareal, D. Aldosterone and antialdosterone therapy in congestive heart failure. Am J Cardiol 1993;71:3A-11A.","journal-title":"Am J Cardiol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(87)90495-5","volume":"83","author":"A Rimondini","year":"1987","unstructured":"Rimondini, A, Cipolla, CM, Della Bella, P, Grazi, S, Sisillo, E, Susini, G, Guazzi, MD. Hemofiltration as a short-term treatment for refractory congestive heart failure. Am J Med 1987;83:43?48.","journal-title":"Am J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","volume":"325","author":"J Cohn","year":"1991","unstructured":"Cohn, J, Johnson, G, Ziesche, S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303?310.","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.1989.03420060100040","volume":"261","author":"LW Stevenson","year":"1989","unstructured":"Stevenson, LW, Perloff, JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884?888.","journal-title":"JAMA"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0735-1097(85)80270-9","volume":"6","author":"DS Weiland","year":"1985","unstructured":"Weiland, DS, Konstam, MA, Salem, DN, Martin, TT, Cohen, SR, Zile, MR, Das, D. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1985;6:171?173.","journal-title":"Am J Cardiol"},{"key":"CR15","first-page":"1429","volume":"316","author":"M Packer","year":"1987","unstructured":"Packer, M. Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure: The price we pay for interfering with evolution. J Am Coll Cardiol 1987;316:1429?1435.","journal-title":"J Am Coll Cardiol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","volume":"2","author":"Captopril Multicenter Research Group","year":"1983","unstructured":"Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983;2:755?763.","journal-title":"J Am Coll Cardiol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"Consensus Trial Study Group","year":"1987","unstructured":"Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429?1435.","journal-title":"N Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0735-1097(90)90174-N","volume":"15","author":"JSR Gibbs","year":"1990","unstructured":"Gibbs, JSR, Keegan, J, Wright, C, Fox, KM, Poole-Wilson, PA. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 1990;15:52?61.","journal-title":"J Am Coll Cardiol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","volume":"71","author":"AA Vliet van","year":"1993","unstructured":"vanVliet, AA, Donker, AJM, Nauta, JJP, Verheugt, FWA. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol 1993;71:21A-28A.","journal-title":"Am J Cardiol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.CIR.74.2.367","volume":"74","author":"J Gage","year":"1986","unstructured":"Gage, J, Rutman, H, Lucido, D, LeJemtel, TH. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 1986;74:367?373.","journal-title":"Circulation"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9149(90)90362-5","volume":"66","author":"JW Nemanich","year":"1990","unstructured":"Nemanich, JW, Veith, RC, Abrass, IB, Stratton, JR. Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 1990;66:843?848.","journal-title":"Am J Cardiol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","volume":"342","author":"F Waagstein","year":"1993","unstructured":"Waagstein, F, Bristow, MR, Swedberg, K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441?1446.","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","volume":"80","author":"F Waagstein","year":"1989","unstructured":"Waagstein, F, Caidahl, K, Wallentin, I, Bergh, CH, Hjalmarson, A. Long-term betablockade in dilated cardiomyopathy. Effects of short and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989;80:551?563.","journal-title":"Circulation"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/01.CIR.85.2.574","volume":"85","author":"M Packer","year":"1992","unstructured":"Packer, M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992;85:50?56.","journal-title":"Circulation"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.80.6.1675","volume":"80","author":"M Luu","year":"1989","unstructured":"Luu, M, Stevenson, WG, Stevenson, LW, Baron, K, Walden, J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989;80:1675?1680.","journal-title":"Circulation"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0735-1097(89)90310-0","volume":"13","author":"RA Winkle","year":"1989","unstructured":"Winkle, RA, Mead, RH, Ruder, MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353?1361.","journal-title":"J Am Coll Cardiol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","volume":"116","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1992","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann Intern Med 1992;116:1?5.","journal-title":"Ann Intern Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00052508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00052508\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00052508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T23:50:38Z","timestamp":1554249038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00052508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":27,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["BF00052508"],"URL":"https:\/\/doi.org\/10.1007\/bf00052508","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}